Evaluation of splenomegaly

最后审阅: 1 Feb 2026
最后更新: 03 Oct 2025

小结

鉴别诊断

常见

  • Alcohol induced
  • Steatotic liver disease
  • Primary biliary cholangitis (PBC)
  • Primary sclerosing cholangitis
  • Hemochromatosis
  • Hodgkin lymphoma
  • Non-Hodgkin lymphoma (NHL)
  • Waldenström macroglobulinemia or lymphoplasmacytic lymphoma
  • Acute myeloid leukemia (AML)
  • Chronic myeloid leukemia (CML)
  • Acute lymphoblastic leukemia (ALL)
  • Chronic lymphocytic leukemia (CLL)
  • Hairy cell leukemia
  • Myelofibrosis
  • Polycythemia vera
  • Essential thrombocytosis
  • Splenic metastases
  • Autoimmune hemolytic anemia
  • Rheumatoid arthritis (RA)
  • Felty syndrome
  • Systemic lupus erythematosus
  • Sarcoidosis
  • Malaria
  • Epstein-Barr virus (EBV)
  • Endocarditis
  • Sepsis-related splenic abscesses
  • Chronic hepatitis C
  • Chronic hepatitis B
  • Sickle cell anemia
  • Cytoskeletal defects
  • Thalassemias
完整详情

不常见

  • Benign splenic tumors
  • Portal vein thrombosis
  • Splenic vein thrombosis
  • Budd-Chiari syndrome
  • Hemophagocytic lymphohistiocytosis (HLH)
  • Amyloidosis
  • Gaucher or Niemann-Pick disease
  • Severe dengue
  • Splenic rupture
  • Subcapsular hemorrhage
  • Secondary to granulocyte colony-stimulating factor (G-CSF)
完整详情

撰稿人

作者

Terri L. Parker, MD

Assistant Professor of Medicine

Section of Hematology

Yale School of Medicine

Smilow Cancer Center at Yale-New Haven

New Haven

CT

利益声明

TLP declares that she has no competing interests.

鸣谢

Dr Terri L. Parker would like to gratefully acknowledge Dr Alan E. Lichtin, the previous contributor to this monograph.

利益声明

AEL has received research support from Amgen.

同行评议者

Priyanka Mehta, MD

Consultant Haematologist

Bristol Haematology and Oncology Centre

Bristol

UK

利益声明

PM declares that she has no competing interests.

Ruben A. Mesa, MD

Professor of Medicine

Mayo Clinic

Scottsdale

AZ

利益声明

RAM declares that he has no competing interests.

Giovanni Barosi, MD

Director of the Laboratory of Clinical Epidemiology

IRCCS Policlinico S. Matteo Foundation

Pavia

Italy

利益声明

GB declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

参考文献

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

关键文献

Shakoory B, Geerlinks A, Wilejto M, et al. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS). Ann Rheum Dis. 2023 Oct;82(10):1271-85.全文  摘要

Gertz MA. Waldenström macroglobulinemia: 2023 update on diagnosis, risk stratification, and management. Am J Hematol. 2023 Feb;98(2):348-58.全文  摘要

Kowdley KV, Brown KE, Ahn J, et al. ACG clinical guideline: hereditary hemochromatosis. Am J Gastroenterol. 2019 Aug;114(8):1202-18.全文  摘要

参考文献

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

内容使用需遵循免责声明